17/05/2021 AC Immune updates on the progress of its pTau vaccine trial for AD, paving the way for expansion to Phase 2b/3 Science watch
13/05/2021 AI-designed antipsychotic drug to enter Phase 1 clinical trials for AD psychosis in the US Science watch
10/05/2021 Cassava Sciences announces the initiation of a cognition maintenance study in Alzheimer’s disease Science watch
10/05/2021 Gregory Branigan discusses impact of estrogen therapies on Alzheimer’s disease pathways Science watch
01/05/2021 Study analysing AT(N) biomarker profiles reveals that individuals with high AD biomarker levels can remain dementia-free Science watch
30/04/2021 TouchNEUROLOGY discusses post-hoc analysis of the LipiDiDiet trial with Tobias Hartmann Science watch
30/04/2021 TouchNEUROLOGY discusses phase 2 MCLENA-1 clinical trial with Marwan Sabbagh Science watch
23/04/2021 TouchNEUROLOGY Editorial Board member Jeffrey Cummings discusses use of BAN2401 in early stage Alzheimer’s disease Science watch
21/04/2021 AgeneBio completes enrolment of its HOPE4MCI Phase IIb trial with people with MCI due to AD Science watch
